HomeInsightsPE

Gennex Laboratories Ltd PE Ratio

Gennex Laboratories Ltd PE Ratio

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

305.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Gennex Laboratories Ltd

NSE: GENNEXLAB

PE

25.3

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Gennex Laboratories Ltd is 25.3 as of 24 Nov 9.00 AM .
  • The P/E Ratio of Gennex Laboratories Ltd changed from 17.3 on March 2019 to 27.2 on March 2024 . This represents a CAGR of 7.83% over 6 years.
  • The Latest Trading Price of Gennex Laboratories Ltd is ₹ 19.21 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Gennex Laboratories Ltd

No data available

Company Fundamentals for Gennex Laboratories Ltd

No data available

Image

Gennex Laboratories Ltd

NSE: GENNEXLAB

Share Price

₹ 19.21

0.25 (1.32%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Gennex Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Gennex Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202419.21
21 Nov 202418.96
19 Nov 202419.22
18 Nov 202419
14 Nov 202419.08
13 Nov 202419.21
12 Nov 202420.14
11 Nov 202420.47
08 Nov 202420.85
07 Nov 202420.77

SWOT Analysis Of Gennex Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gennex Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gennex Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Gennex Laboratories Ltd25436
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Gennex Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gennex Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Gennex Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Gennex Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Gennex Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gennex Laboratories Ltd

No data available

* All values are in %

About Gennex Laboratories Ltd

  • Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985.
  • The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates.
  • It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.
  • The company thrives on the strength of its exports to various countries viz.
  • Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others.

Gennex Laboratories Ltd News Hub

News

Gennex Laboratories consolidated net profit rises 63.51% in the June 2024 quarter

Net profit of Gennex Laboratories rose 63.51% to Rs 4.66 crore in the quarter ended June 2...

Read more

2024-08-16 00:00:00

News

Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Aug...

Read more

2024-08-07 00:00:00

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 Sept...

Read more

2024-08-28 00:00:00

News

Gennex Laboratories AGM scheduled

Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company wi...

Read more

2024-09-11 00:00:00

News

Gennex Laboratories schedules board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nov...

Read more

2024-11-07 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gennex Laboratories Ltd

What is the current PE Ratio of Gennex Laboratories Ltd?

The Current PE Ratio of Gennex Laboratories Ltd is 25.28 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Gennex Laboratories Ltd last year?

The PE Ratio of Gennex Laboratories Ltd was 20.78 last year, now the PE ratio is 25.28, showing a year-on-year growth of 21.7%.

What does the PE Ratio of Gennex Laboratories Ltd indicate about its stock?

The PE Ratio of Gennex Laboratories Ltd is 25.28. This ratio indicates that investors are willing to pay 25.28 times the earnings per share for each share of Gennex Laboratories Ltd.

What is the PE Ratio Growth of Gennex Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gennex Laboratories Ltd grew by 21.7% whereas, the EPS ratio grew by 10.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*